Introduction to the Stem Cell Biobanking Market
“Stem cell biobanking” is the cryogenic storage of stem cells, or biological samples containing stem cells, for use at a later point in time. Therefore, the “stem cell biobanking market” is defined as the total annual revenue derived from the storage of:
- Stem cell lines and their derivatives
- All biological samples that were collected specifically because they contain stem cell populations (e.g. cord blood, adipose tissue, and more)
For company executives and investors that are competing within the stem cell biobanking marketplace, it is important to know the nine market segments that compose the stem cell biobanking market at large.
Stem Cell Biobanking Market Segments
Stem cell biobanks may store stem cells for several different reasons, each of which represents a distinct market segment, as shown in the table below.
STEM CELL BIOBANKING MARKET SEGMENTS |
|
| Description of Stem Cell Storage | Types of Stem Cells Stored |
| 1. Cord Blood Units | Contains hematopoietic and mesenchymal stem cells (“cord blood” stem cells) |
| 2. Bone Marrow & Peripheral Blood Specimens | Contains hematopoietic and mesenchymal stem cells |
| 3. Dental Pulp Samples | Contains mesenchymal stem cells |
| 4. Adipose Specimens | Contains adipose-derived stem cells |
| 5. Amniotic Fluid Specimens | Contains amniotic stem cells, which are multipotent stem cells of mesenchymal origin. |
| 6. Storage of Assisted Reproduction Specimens | Stored embryos can be used to derive embryonic stem cells |
| 7. Storage of Stem Cells for Use in Medical Applications | All types of stem cells |
| 8. Storage of Stem Cells for Use in Scientific Research | All types of stem cells |
| 9. Related Markets | Related markets could potentially include the storage of other types of cells than stem cells, as well as the storage of human tissue, plasma, serum, DNA & RNA |
Please note that there may be some limited overlap of these market segments. For instance, cord blood stem cells have the potentially to be used for medical applications or scientific research. However, the vast majority of cord blood stem cells (more than 99%) remained cryogenically preserved. As such, cord blood stem cells should largely be considered a distinct and unique market segment. The same is true of the other market segments listed above.
When you have a thorough understanding of the market segments that compose the stem cell biobanking market, you are positioned to target and dominate the niche best suited to your company’s talents, personnel, and experience. With a clear understanding of these storage purposes, it is also easier to identify recent and near-term market opportunities in the rapidly-evolving stem cell biobanking market.
To learn more about the stem cell biobanking market, view the global strategic report, “The Market for Stem Cell Biobanking and Storage – Size, Segments, and Trends.”
To receive future posts about the stem cell industry, sign-up here. We will never share your information with anyone, and you can opt-out at any time. No spam ever, just great stuff.
About Us
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant has been featured on news outlets including the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking.
Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, and Thermo Fisher Scientific, BioInformant is your global leader in stem cell industry data.